| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11033-008-9278-4 |
| P698 | PubMed publication ID | 18516702 |
| P50 | author | Rami Mahfouz | Q89425616 |
| Zaher K Otrock | Q95940767 | ||
| P2093 | author name string | Ali Taher | |
| Elias Kfoury | |||
| Said Saghieh | |||
| P2860 | cites work | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
| Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation | Q28175580 | ||
| Prevalence of protein C deficiency in the healthy population | Q28300966 | ||
| Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients | Q29999663 | ||
| Genetic factors contribute to bleeding after cardiac surgery. | Q33215058 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Successful renal transplantation in a patient with heterozygous prothrombin gene, factor V Leiden mutation and heparin-induced thrombocytopenia using r-hirudin as anticoagulant | Q33370351 | ||
| Vascular disease in the antiphospholipid syndrome: A comparison with the patient population with atherosclerosis | Q33374176 | ||
| Ischemic heart disease associated with protein C deficiency | Q74561604 | ||
| Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene | Q77088383 | ||
| Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting | Q77143731 | ||
| Multifocal embolic strokes following cardiac surgery in a protein C-deficient child | Q77768176 | ||
| Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease | Q77799021 | ||
| APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study | Q77812969 | ||
| Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis | Q78238009 | ||
| The antiphospholipid syndrome | Q78470187 | ||
| The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1 | Q78617944 | ||
| Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? | Q79779684 | ||
| Kidney and pancreas transplantation in the United States, 1996-2005 | Q80145643 | ||
| Thrombophilia and avascular necrosis of femoral head in kidney allograft recipients | Q80250751 | ||
| Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder? | Q81896594 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques | Q33750971 | ||
| Vascular rejection with tacrolimus and potential long-term graft outcome | Q33781430 | ||
| Epidemiology of the antiphospholipid antibody syndrome | Q33916234 | ||
| A prospective study of the incidence of deep-vein thrombosis within a defined urban population | Q33977258 | ||
| World distribution of factor V Leiden | Q34057587 | ||
| A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. | Q34407258 | ||
| Hypercoagulability syndromes | Q34432158 | ||
| Epidemiology of factor V Leiden: clinical implications | Q34474241 | ||
| A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery | Q34689934 | ||
| MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. | Q34974721 | ||
| Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects | Q35081834 | ||
| Actions and Interactions of Antithrombin and Heparin | Q35148665 | ||
| Review of clinical trials of low molecular weight heparins | Q35255436 | ||
| Factor V Leiden and perioperative risk | Q35779440 | ||
| Prevalence and risk of thrombophilia defects in vascular patients. | Q35827027 | ||
| Do we need screening for thrombophilia prior to kidney transplantation? | Q35829472 | ||
| Thrombophilia and new anticoagulant drugs | Q35961838 | ||
| Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases | Q36044569 | ||
| Genetics of coagulation: considerations for cardiac surgery | Q36697910 | ||
| The role of emergent exploration in free-tissue transfer: a review of 150 consecutive cases | Q37947281 | ||
| Risk factors for myocardial infarction during coronary artery bypass graft surgery | Q38709719 | ||
| Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery | Q39638109 | ||
| Antithrombin III: critical review of assay methods. Significance of variations in health and disease | Q39725629 | ||
| Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy | Q40499007 | ||
| A single center's experience with 308 free flaps for repair of head and neck cancer defects | Q40718313 | ||
| Protein C deficiency in microvascular head and neck reconstruction | Q41746610 | ||
| No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study | Q42165716 | ||
| Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine eras | Q44063406 | ||
| Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation | Q45100303 | ||
| Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families | Q45889288 | ||
| Postoperative thrombotic complications in patients with lupus anticoagulant: increased risk after vascular procedures | Q46298505 | ||
| Recovery of allograft function after complete withdrawal of immunosuppression | Q46874614 | ||
| Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery | Q47220344 | ||
| Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study | Q47221331 | ||
| Efficacy and safety of low molecular weight heparin in renal transplantation. | Q47281668 | ||
| Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement | Q47324889 | ||
| Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. | Q47819941 | ||
| High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. | Q47917100 | ||
| No correlation between activated protein C resistance and free flap failures in 100 consecutive patients | Q47983243 | ||
| The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty | Q48340094 | ||
| Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency | Q48708173 | ||
| Ischemic stroke of unusual cause: clinical features, etiology and outcome. | Q48827606 | ||
| Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. | Q50143636 | ||
| Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. | Q50225871 | ||
| A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. | Q50549660 | ||
| The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. | Q50654151 | ||
| Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty. | Q50932862 | ||
| Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases. | Q51414878 | ||
| Hyperhomocysteinemia and venous thrombosis: a meta-analysis. | Q51565947 | ||
| Genetic thrombophilia in patients with VTE in eastern Mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making? | Q51942184 | ||
| Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. | Q52248767 | ||
| Prevalence of antithrombin deficiency in the healthy population. | Q52881544 | ||
| Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. | Q53851814 | ||
| Experience with 500 simultaneous pancreas-kidney transplants. | Q54124730 | ||
| Early loss of renal transplants in patients with thrombophilia. | Q54138827 | ||
| Activated protein C resistance: prevalence and implications in peripheral vascular disease. | Q54154473 | ||
| Resistance to activated protein C as a basis for venous thrombosis. | Q54214042 | ||
| Methylenetetrahydrofolate reductase mutation and neural tube defects | Q57677615 | ||
| The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis | Q61634614 | ||
| Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency | Q61634625 | ||
| Hypercoagulability in patients with peripheral vascular disease | Q66964691 | ||
| Screening for hypercoagulable states in vascular surgical practice: a preliminary study | Q68828176 | ||
| Hypercoagulable states and lower limb ischemia in young adults | Q69294252 | ||
| The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis | Q70052725 | ||
| Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction | Q70652581 | ||
| Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn | Q70811173 | ||
| Spina bifida, 677T-->C mutation, and role of folate | Q70874277 | ||
| Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo | Q71200603 | ||
| Early coronary artery bypass graft thrombosis in a patient with protein S deficiency | Q71557736 | ||
| Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies | Q71764988 | ||
| Hypercoagulable states in patients with leg ischaemia | Q72091911 | ||
| Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis | Q72414738 | ||
| Vascular reconstruction in 105 consecutive pancreas transplants | Q72670674 | ||
| Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V | Q72681302 | ||
| Lower limb ischaemia in primary antiphospholipid syndrome | Q72898006 | ||
| Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients | Q73060591 | ||
| Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin) | Q73069450 | ||
| Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection | Q73086224 | ||
| Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study | Q73352964 | ||
| The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis | Q73418157 | ||
| Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene | Q73774609 | ||
| Coronary thrombosis associated with antithrombin-III deficiency | Q73778580 | ||
| Genetic predisposition to thrombosis in renal transplant recipients: the factor V Q506 (Leiden) allele | Q73847289 | ||
| Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection | Q73847312 | ||
| Aprotinin, cardiac surgery, and factor V Leiden | Q74029569 | ||
| Familial clustering of factor VIII and von Willebrand factor levels | Q74286671 | ||
| Investigation and management of heritable thrombophilia | Q74502662 | ||
| P433 | issue | 5 | |
| P921 | main subject | thrombophilia | Q1570013 |
| P304 | page(s) | 1041-1051 | |
| P577 | publication date | 2008-05-31 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | The impact of inherited thrombophilia on surgery: a factor to consider before transplantation? | |
| P478 | volume | 36 |
| Q38544987 | Antiphospholipid syndrome, antiphospholipid antibodies and solid organ transplantation. |
| Q38860152 | Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency |
| Q62071585 | The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria |
Search more.